Endogenous type C particles from rat embryo cells treated with 5-bromodeoxyuridine.
D000818:Animals; D000831:Animals, Newborn; D000956:Antigens, Viral / Q000032:analysis; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured / Q000187:drug effects / Q000201:enzymology / Q000382:microbiology; D002499:Centrifugation, Density Gradient; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004622:Embryo, Mammalian / Q000201:enzymology / Q000382:microbiology*; D005455:Fluorescent Antibody Technique; D051379:Mice; D008854:Microscopy, Electron; D009374:Neoplasms, Experimental / Q000209:etiology; D051381:Rats; D011920:Rats, Inbred WF; D012190:Retroviridae / Q000302:isolation & purification*; D013997:Time Factors; D014316:Tritium; D014529:Uridine
D000956:Antigens, Viral; D014316:Tritium; D004254:DNA Nucleotidyltransferases; D001973:Bromodeoxyuridine; D014529:Uridine